
WDB coco Co., Ltd.
7079.TJPXIndustrialsSpecialty Business Services
Latest quote
¥2,583
+¥1.00 · +0.04%
7079.T company overview
Company profile
Company websiteWDB coco Co., Ltd. offers specialized contractual services to pharmaceutical companies throughout Japan. The firm plays a crucial role in advancing pharmaceuticals and medical devices, with a particular focus on safety information management, support for safety data systems, clinical research assistance, and post-market safety operations. Its offerings also encompass translation and quality control document preparation, additional clinical study support, and personnel dispatch. Furthermore, WDB coco provides comprehensive post-marketing surveillance (PMS) solutions, which include securing agreements with healthcare facilities, explaining survey protocols, collecting survey forms, conducting detailed monitoring (like re-surveys), managing a central case registration center, handling data, and performing statistical analyses. Established in 1984, the company's headquarters are located in Tokyo, Japan.
- Industry
- Specialty Business Services
- Sector
- Industrials
- Headquarters
- JP
- CEO
- Haruhiko Taniguchi
- Listed since
- Dec 26, 2019
- Employees
- 516
Market position
- Volume
- 100
- 0.07× average
- Average volume
- 1.51K
- Average daily volume
- Market cap
- 6.21B JPY
- Beta
- 0.2
- Market reference 1
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 2.56B JPY
- P/E (TTM)
- 0.95×
- P/B (TTM)
- 0.03×
- P/S (TTM)
- 0.11×
- EV / EBITDA
- 2.52×
- Earnings yield
- 10.89%
- Free cash flow yield
- 8.36%
- Dividend yield
- 3.68%
Profitability & efficiency
- Gross margin
- 33.86%
- Operating margin
- 17.54%
- Net margin
- 12.11%
- Return on equity
- 14.20%
- Return on assets
- 11.91%
- Return on invested capital
- 13.24%
Financial health
- Debt / equity
- 0.01×
- Current ratio
- 7.8×
Earnings
- Latest EPS result
- 57.27
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
7079.T peers
Continue in GoAI
Research 7079.Tresearch.disclaimer





